S-100β protein in serum, a tumor marker in malignant melanoma current state of knowledge and clinical experiences;S-100β-protein im serum als tumormarker beim malignenmelanom. Aktueller kenntnisstand und klinische erfahrungen

Hautarzt

Volumn 50, Issue 4, 1999, Pages 250-256

  Jäckel, Andreas ^a   Deichmann, Martin ^a   Waldmann, Volker ^a   Bock, Michael ^a   Näher, Helmut ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Malignant melanoma; Prognosis; Serum 5100 protein; Tumor marker

Indexed keywords

CALCIUM BINDING PROTEIN; PROTEIN P53; PROTEIN S 100; TUMOR MARKER;

CANCER STAGING; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN STRUCTURE; REVIEW; TUMOR SUPPRESSOR GENE;

HUMANS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 16744368289     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050897     Document Type: Review

References (39)

1. Abraha HD, Fuller LC, Du Vivier AWP, Higgins EM, Sherwood RA (1997) Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. Br J Dermatol 137:381-385
2. Allore RJ,Friend WC, O'Hanlon D, Neilson KM, Baumal R, Dunn RJ, Marks A (1990) Cloning and expression of the human S100 beta gene. J Biol Chem 265:15537-15543
3. Barger SW, Wolchok SR, Van Eldik LJ (1992) Disulfide-linked S 100β dimers and signal transduction. Biochim Biophys Acta 1160:105-112
4. Baudier J, Briving C, Dienum J (1982) Effect of S-100 protein and calmodulin on calcium-induced disassembly of brain microtuble proteins in vitro. FEBBS Lett 147:165-168
5. Baudier J, Delphin C, Grunwald D, Khochbin S, Lawrence JJ (1992) Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S 100b-binding protein. Proc Natl Acad Sci 89:11627-11631
6. Brossart P, Schmier MW, Krüger S, Willhauk M, Scheibenbogen C, Möhler T, Keilholz U(1995) A polymerase chain reaction-based semi-quantitative assessment of malignant melanoma cells in peripheral cells. Cancer Res 55:4065-4068
7. Cho KH, Hashimoto K, Taniguchi Y, Pietruk T, Zarbo RJ, An T (1990) Immunhistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer 66:765-771
8. Clapham DE (1995) Calcium Signaling. Review. Cell 80:259-268
9. Donato R (1991) Perspectives in S-100 protein biology. Cell Calcium 12:713-726
10. Egan MJ, Crocker J, Newman J, Collard M (1986) Immunohistochemical localization of S100 protein in skin tumors. Arch Pathol Lab Med 110:765-767
11. Fagnart OC, Sindic CJM, Laterre C (1988) Particle counting immunoassay of S100 protein in serum:Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 34:1387-1391
12. Foss AJE, Guille MJ, Ocdeston NL, Hykin PG, Hungerford JL, Lightman S (1995) The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72:155-159
13. Ghanem G, Loir B, Sales F, Pector JC, Ewalenko P, Kerger J, Liènard D, Lejuene F, Deraemaecker F, Frühling J (1997) Serum protein S-100 is a useful marker in metastatic melanoma. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S55
14. Ghanem G, Loir B, Sales F, Pector JC, Ewalenko P, Kerger J, Liènard D, Lejuene F, Deraemaecker F, Frühling J (1997) Serum protein S-100 is a useful marker in metastatic melanoma. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S55
15. Guo HB, Stoffel-Wagner B, Bierwirth T, Mezger J, Klingmüller D (1995) Clinical significance of serum S100 in metastatic malignant melanoma. Eur J Cancer 31:924-928
16. Hauschild A, Engel G, Brenner W, Gläser R, Henze E, Christophers E (1997) Sangtec S-100β is a reliable serum marker for metastatic melanoma. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S55
17. Hauschild A, Engel G, Brenner W, Gläser R, Henze E, Christophers E (1997) Sangtec S-100β is a reliable serum marker for metastatic melanoma. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S55
18. Henze G, Dummer R, Joller-Jemelka H, Böni R, Burg G (1997; Serum S100 - a marker for disease monitoring in metastatic melanoma. Dermatology 194:208-212
19. Isobe T, Okuyema T (1978) The amino acid sequence of S10O protein (PAP-1b) and its relationship to calcium binding proteins. Eur J Biochem 89:379-388
20. Isobe T, Ishioka N, Okuyama T (1981) Structural relation of two S-100 proteins in bovine brain, subunit composition of S-100a proteins. Eur J Biochem 115:496-474
21. Kaskel P, Nolte A, Krähn G, Peter RU (1997) S100 im Serum: Tumormarker und Verlaufsparameter. Abstract, präsentiert auf 7. Jahrestagung der ADO; Kiel 09/97 H+G 72 (9):693 Abstract V29:693
22. Kligman D, Hilt DC (1988) The S 100 protein family. Trends Biochem Sci 13:437-443
23. Krähn G, Kaskel P, Nolte A, Peter RU (1997) S-100 protein in peripheral blood: a tumour marker for malignant melanoma. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S94
24. Krähn G, Kaskel P, Nolte A, Peter RU (1997) S-100 protein in peripheral blood: a tumour marker for malignant melanoma. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S94
25. Moore BW (1965) A soluble protein characterisic of the nervous system. Biochem Biophys Res Comm 19:739-744
26. Nakajima T, Sato Y, Watanabe S (1982) Immunoelectron microscopical demonstration of S100 protein in epidermal Langerhans' cells. Biomed Res 3:226-231
27. Orfanos CE, Jung EG, Rassner G, Wolff HH, Garbe C (1994) Stellungnahme und Empfehlungen der Kommission malignes Melanom der Deutschen Dermatologischen Gesellschaft zur Diagnostik, Behandlung und Nachsorge des malignen Melanoms der Haut. Stand 1993/94. Hautarzt 45:285-291
28. Persson L, Hardmark HG, Gustaffson J (1987) S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum, markers of cell demage in human central nervous system. Stroke 18:911-918
29. Peterson LL, Woodward WR, Fletscher WS, Palmquist M, Tucker MA, Illias A (1988) Plasma 5-S-Cysteinyldopa differentiates patients with primary and metastatic malanoma from patients with dysplastic nevus syndrom and normal subjects. J Am Acad Dermatol 19:509-515
30. Rankin EM, Korse CM, Bonfrer JMG (1997) The prognostic value of circulating protein S-100β in malignant melanoma patients. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S56
31. Rankin EM, Korse CM, Bonfrer JMG (1997) The prognostic value of circulating protein S-100β in malignant melanoma patients. Abstract präsentiert auf 4. World Conference on melanoma, Sydney, Australien, 06/97; Melanoma Res 7:S56
32. Schäfer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW (1995) Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: Rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25:638-643
33. Schwartze G, Fiedler H (1994) Zur diagnostischen Bedeutung des α-MSH beim malignen Melanom des Menschen. Hautarzt 45:468-470
34. Takahashi K, Isobe T, Ohutski Y (1984) Immunohistochemical localization and distribution of S100 proteins in the human lymphoreticular system. Am J Patholl 16:497-503
35. Takahashi K, Isobe T, Ohtsuki Y, Akagi T, Sonobe H, Okuyama T (1984) Immunohistochemical study on the distribution of alpha and beta subunits of S100 protein in human neoplasm and normal tissues. Virchows Arch Cell Pathol 45:385-396
36. von Schoultz E, Hansson LO, Djureen E, Hansson J, Kärnell R, Nilsson B, Stigbrand T, Ringborg U (1996) Prognostic value of serum analyses of S-100β protein in malignant melanoma. Melanoma Res 6:135-137
37. Wakamatsu K, Ito S (1995) Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxy-indole-2-carboxylic acid in healthy Japanese. Pigment Cell Res 8:132-134
38. Westaby S, Johnsson P, Parry AJ, Blomqvist S, Solem JO, Alling C, Pillali R, Jaggart DP, Grebenik C, Stahl E (1996) Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 61:88-92
39. Wicki R, Schafer BW, Erne P, Heizmann CW (1996) Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. Biochem Biophys Res Commun 227:594-599